Literature DB >> 7757057

A cell culture system for study of the development of Toxoplasma gondii bradyzoites.

L M Weiss1, D Laplace, P M Takvorian, H B Tanowitz, A Cali, M Wittner.   

Abstract

Toxoplasma gondii is a ubiquitous apicomplexan parasite and a major opportunistic pathogen under AIDS-induced conditions, where it causes encephalitis when the bradyzoite (cyst) stage is reactivated. A bradyzoite-specific Mab, 74.1.8, reacting with a 28 kDa antigen, was used to study bradyzoite development in vitro by immuno-electron microscopy and immunofluorescence in human fibroblasts infected with ME49 strain T. gondii. Bradyzoites were detected in tissue culture within 3 days of infection. Free floating cyst-like structures were also identified. Western blotting demonstrated the expression of bradyzoite antigens in these free-floating cysts as well as in the monolayer. Bradyzoite development was increased by using media adjusted to pH 6.8 or 8.2. The addition of gamma-interferon at day 3 of culture while decreasing the total number of cysts formed prevented tachyzoite overgrowth and enabled study of in vitro bradyzoites for up to 25 days. The addition of IL-6 increased the number of cysts released into the medium and increased the number of cysts formed at pH 7.2. Confirmation of bradyzoite development in vitro was provided by electron microscopy. It is possible that the induction of an acute phase response in the host cell may be important for bradyzoite differentiation. This system should allow further studies on the effect of various agents on the development of bradyzoites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7757057     DOI: 10.1111/j.1550-7408.1995.tb01556.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  59 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

2.  Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation.

Authors:  Y W Zhang; K Kim; Y F Ma; M Wittner; H B Tanowitz; L M Weiss
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

3.  Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression.

Authors:  Michael D Cleary; Upinder Singh; Ira J Blader; Jeremy L Brewer; John C Boothroyd
Journal:  Eukaryot Cell       Date:  2002-06

4.  Dynamics of Toxoplasma gondii differentiation.

Authors:  Florence Dzierszinski; Manami Nishi; Lillian Ouko; David S Roos
Journal:  Eukaryot Cell       Date:  2004-08

5.  Histone-modifying complexes regulate gene expression pertinent to the differentiation of the protozoan parasite Toxoplasma gondii.

Authors:  Nehmé Saksouk; Micah M Bhatti; Sylvie Kieffer; Aaron T Smith; Karine Musset; Jérôme Garin; William J Sullivan; Marie-France Cesbron-Delauw; Mohamed-Ali Hakimi
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

6.  Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii.

Authors:  Michael S Eaton; Louis M Weiss; Kami Kim
Journal:  Int J Parasitol       Date:  2005-09-22       Impact factor: 3.981

7.  Disruption of a locus encoding a nucleolar zinc finger protein decreases tachyzoite-to-bradyzoite differentiation in Toxoplasma gondii.

Authors:  Padmini Vanchinathan; Jeremy L Brewer; Omar S Harb; John C Boothroyd; Upinder Singh
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

8.  Externally triggered egress is the major fate of Toxoplasma gondii during acute infection.

Authors:  Tadakimi Tomita; Tatsuya Yamada; Louis M Weiss; Amos Orlofsky
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

9.  Bradyzoite development in Toxoplasma gondii and the hsp70 stress response.

Authors:  L M Weiss; Y F Ma; P M Takvorian; H B Tanowitz; M Wittner
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

10.  Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade.

Authors:  Rajarshi Bhadra; Jason P Gigley; Louis M Weiss; Imtiaz A Khan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.